Member Info for kezzman

only tip of the iceberg here and more will come to light as they dig deeper

wonder what price they will raise at?

Will they do a near term placing?

share muppets are telling everyone to hold on while they sel their stockl lol Shares in Amryt Pharma (AMYT) have surged to 26p-26.5p so we are well up on the share tip price (18.4p offer) and within spitting distance of the 28p+ to sell target. But hang on tight pro tem... The only news this week is a smallish director share purchase. Markus Ziener, Non-Executive Director, has purchased 100,000 ordinary shares of 1p each at a price of 21.5p per share. Following this transaction, Mr Ziener holds 100,000 shares, representing 0.05% of the company's issued share capital (excluding treasury shares). Mr Ziener is the Executive Managing Director of Software AG Stiftung, a 20.9% shareholder in Amryt. So Ziener clearly knows Amryt well. That is one reason for the shares bubbling higher. The others are those incredibly bullish broker notes with targets of 60p (HERE) and 88p (HERE). And as importantly, mounting excitement about the phase 3 trials of Episalvan, a treatment for EB - a global market worth $1.3 billion per annum. Any whiff of good news on that front could see the shares really race ahead suddenly making those broker targets seem far less fanciful than they might appear now. So despite the sharp jump in the share price yesterday, the stance stays as HOLD.

spunked half a million quid of sh cash on jack and still nothing defo and not until Q2 at the earliest Q2 wtf be another half million done leave sh with fa then do another equity raise this kind of thing should be outlawed disgrace should of just handed sh their cash back

you ****s

share to illiquid for any rise from here most locked in now need some more figures from that RNS and some more news

at its finest hope no one got impaled

hope we can close above 22.50

and impaled on the spike

but can you get out again no figures in the RNS

The Company is in discussions with potential new investors and existing shareholders with respect to a placing of new shares to raise between £1 million to £2 million at a discount to the current share price.

your a billionare how about dipping into your amassed fortune and seeing small shareholders right here give us something back here you ****

wtf happening here nice to hear the PR department firing on all cylinders more poo poo

fishy price action

they love a placing this mob nicely forward sold into the recent rise

Batangas write-down – significant write-down in the accounts of the value of the project and plenty of warnings about a potential inability to fund it going forward. This has been superceded to a certain extent by this week’s announcement which states that it is not planning any major expenditure in the Philippines this year due to the uncertainty in the mining sector. Copper concentrate trading stalled – no real mention of it; one line states that ore trading has been stopped while the mining sector is so unsettled. It does state that it has written off the loan of $205,000 due from its copper concentrate supplier though which doesn’t sound very encouraging. Looks like they generated $50,000 revenue in the year from it though, with a cost of sales of a similar amount – wow! Wreck of a balance sheet – all the cash has gone. As at 31 December 2016, the cash balance was $25,000 and the net current liability position was $233,000 with a further $590,000 of non-current liabilities. This week the company announced that it is planning to get involved with two South Korean mines with ASX listed Southern Gold. Great - all it needs is $1 million and A$500,000 to get its 50% share. So, in summary, it has no real business in the Philippines at the moment, has no cash, its debts are piling up and it now has to find a new load of cash for these new assets. To play safe, it probably needs to raise close to £2 million to get those assets, pay its bills over the next 12 months and sort out its balance sheet. Its current share price is around 2p valuing the business at £3.8 million. Hmmm, I accept that there is some inherent value in Batangas but I’m not putting much value on it right now. One should remember that its old partner sold it 75% of it in December 2016 for 1.25 million shares in Bluebird and a 1% royalty, a pretty negligible sum. With the copper concentrate trading on hold, what are people actually putting a value on? Personally, I wouldn’t buy at 1p, particularly as a massive placing is necessary. If you do like the story, just contact the new broker, SP Angel, and get in the placing instead which I assume will be at a significant discount to the current price.

This week’s strategy update from Bluebird Merchant Ventures (BMV) reminded me that I meant to go searching for its interims as it had done that really annoying thing that rubbish companies do in not actually putting the interims in the RNS, but merely putting a link to the website and then it isn’t actually on the website till later. Having finally tracked them down, I now realise why the company wanted to hide them away as they make horrific reading. Where to start? I should remind you that this only came to the market (Standard List, obvs) in April 2016 and should have had 12 months funding at that time, although to be fair, it did flag as a risk that it would need more funding after a year. Also, it must be said it hasn’t had the best of luck. When it came to the market, its flagship project was the Batangas gold project in the Philippines and almost immediately, mining projects in that part of the world started to look a bit ropey. It then bigged up its copper concentrates trading opportunity although that had gone a bit quiet since last July. That’s enough background, let’s have a look at the half-year numbers to 31 December 2016 that one can access

doing wonders for the sp BOD seem confused placing ahoy next would you take em up on it no thanks i'm out

just hope length of time they are taking will equate with how big their plans are. just have to endure the inevitable sp drift